Navigation

NICE announces members of new Diagnostics Advisory Committee

The National Institute for Health and Care Excellence (NICE) has today (1 April) announced the appointment of the members of its independent Diagnostics Advisory Committee, which was set up to evaluate diagnostic technologies and make recommendations for their use within the NHS in England. This follows the recent announcement of Professor Adrian Newland as Chair of the Committee.

The Committee members are:

  • Professor Ron Akehurst, Dean of the School of Health and Related Research (ScHARR), Professor in Health Economics, University of Sheffield
  • Dr Trevor Cole, Consultant Clinical and Cancer Geneticist, Birmingham Women's Healthcare Trust
  • Dr Paul Collinson, Consultant Chemical Pathologist, St George's Hospital, London
  • Professor Ian Cree, Director, NHS National Institute for Health Research, Evaluation Trials and Studies Evaluating Centre - Efficacy and Mechanism Evaluation programme (NETCC-EME)
  • Dr Erika Denton, National Lead for Diagnostic Imaging and Consultant Radiologist, Norfolk and Norwich University Hospital NHS Foundation Trust
  • Dr Simon Fleming, Consultant in Clinical Biochemistry and Metabolic Medicine, Royal Cornwall Hospital
  • Professor Lisa Hall, Professor of Analytical Biotechnology, University of Cambridge
  • Professor Chris Hyde, Professor of Public Health and Clinical Epidemiology, Peninsula College of Medicine and Dentistry
  • Professor Noor Kalsheker, Clinical Lead for Clinical Pathology and Professor of Clinical Chemistry, Nottingham University Hospitals NHS Trust
  • Dr Mark Kroese, Consultant in Public Health Medicine, Peterborough Primary Care Trust
  • Professor Dietrich Mack, Professor of Medical Microbiology and Infectious Diseases, University of Swansea
  • Dr Richard Nicholas, Consultant Neurologist and Senior Honorary Lecturer, Heatherwood and Wexham Park NHS Trust and Imperial College Healthcare NHS Trust
  • Ms Margaret Ogden, lay member
  • Dr. Diego Ossa, Head, Health Economics and Outcomes Research, Novartis Molecular Diagnostics
  • Mr Stuart Saw, Director of Finance, Tower Hamlets PCT
  • Professor Mark Schulpher, Professor of Health Economics, University of York
  • Dr Steve Thomas, Senior Lecturer and Consultant Radiologist, University of Sheffield
  • Mr Paul Weinberger, Diagnostics Industry Consultant
  • Mr Christopher Wiltshire, lay member

NICE also announced the appointment of the Specialist Committee members for the pilot topic (non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol related liver disease). Specialist members with expertise in the topic under consideration are appointed to the Committee for the duration of the assessment of each topic. The Specialist Committee members for the pilot are:

  • Dr Andrew Holt, Consultant Hepatologist, Queen Elizabeth Hospital, Birmingham
  • Mrs Helen Manley, Web and Publications Development Officer, British Liver Trust
  • Dr Marsha Morgan, Reader in Medicine and Honorary Consultant Physician, University College London
  • Mrs Gerri Mortimore, Lead Liver Nurse Specialist, Derby Hospitals NHS Foundation Trust
  • Dr Phil Newsome, Senior Lecturer in Hepatology and Honorary Consultant Physician, University Hospitals Birmingham NHS Foundation Trust
  • Dr Helen Reeves, Senior Lecturer and Honorary Consultant Gastroenterologist, University of Newcastle Medical School
  • Dr Sandy Smith, Clinical Scientist, Central Manchester University Hospitals NHS Trust

The new Advisory Committee will assess and interpret evidence on the clinical and cost effectiveness of diagnostic technologies, and develop recommendations on their use in the NHS in England. Diagnostic technologies include:

  • Pathological tests such as blood tests
  • Imaging such as X-rays
  • Endoscopy (looking inside the body using an endoscope)
  • Physiological measurement (looking at the function of major organs)

Professor Newland commented: "I am very pleased that we are now able to announce the members of these Committees. They are all well-respected and recognised figures in the fields of diagnostics, health economics, clinical research, public health and industry who, together with our two lay members, will, I'm sure, prove to be a great asset to NICE's diagnostics programme. I look forward to working with them and producing guidance that is based on the best available evidence, and which will have a positive impact on patient care."

This page was last updated: 14 May 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.